According to Piper Jaffray, Physicians Formula FACE gross revenue increased in the high-single-digits during FQ2.
Piper Jaffray said that this was offset by $2.7 million in incremental consumer and trade promotion spending (a contra-revenue item), thus net sales were up 0.6% y/y in FQ2 versus our estimate of +2.4%. “Despite the slight revenue shortfall, management remains optimistic about this year's class of new products, which saw point-of-sale revenue growth of 19% y/y during FQ2. Net sales and EPS guidance were reaffirmed for FY11.”
Physicians Formula closed yesterday at $3.25.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in